Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Q. Li (South San Francisco, United States of America), A. Birnberg (South San Francisco, United States of America), A. Chakrabarti (South San Francisco, United States of America), D. Choy (South San Francisco, United States of America), E. Verschueren (South San Francisco, United States of America), M. Neighbors (South San Francisco, United States of America), W. Sandoval (South San Francisco, United States of America), C. Rosenberger (South San Francisco, United States of America), M. Grimbaldeston (South San Francisco, United States of America), W. Tew (South San Francisco, United States of America). Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD). 5117

Member's Comments

No comment yet.

Related content which might interest you: Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Carboxyhemoglobin (COHb) and bilirubin levels increase with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002 Study on the relation between serum complement (C3, C4) levels and acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005